NC
RGEN icon

NZS Capital’s Repligen RGEN Stock Holding History

NZS Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28M Buy
205,257
+2,032
+1% +$250K 0.73% 43
2026
Q1 		$23.9M Buy
203,225
+4,422
+2% +$618K 0.8% 45
2025
Q4 		$32.6M Buy
198,803
+2,026
+1% +$317K 1% 41
2025
Q3 		$26.3M Buy
196,777
+51,483
+35% +$6.25M 0.81% 44
2025
Q2 		$18.1M Buy
145,294
+13,372
+10% +$1.7M 0.61% 49
2025
Q1 		$16.8M Sell
131,922
-1,772
-1% -$273K 0.76% 46
2024
Q4 		$19.2M Buy
133,694
+5,855
+5% +$840K 0.82% 44
2024
Q3 		$19M Buy
127,839
+3,617
+3% +$519K 0.74% 48
2024
Q2 		$15.7M Buy
124,222
+42,700
+52% +$6.69M 0.64% 48
2024
Q1 		$15M Sell
81,522
-954
-1% -$182K 0.62% 46
2023
Q4 		$14.8M Buy
82,476
+45,272
+122% +$7.05M 0.78% 43
2023
Q3 		$5.92M Buy
37,204
+8,672
+30% +$1.42M 0.32% 58
2023
Q2 		$4.04M Buy
+28,532
New +$4.57M 0.2% 63

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NZS Capital's RGEN Position: Q2 2026 in Review

NZS Capital increased its Repligen (RGEN) stake by 1% in Q2 2026, buying an estimated $250K and bringing the position to 205,257 shares worth $28M. The position accounts for 0.73% of the portfolio, ranked #43.

NZS Capital first reported a position in RGEN in Q2 2023 and has held it in 13 quarters since. The position peaked at $32.6M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • NZS Capital held 205,257 shares of Repligen worth $28M as of Q2 2026.
  • NZS Capital bought 2,032 Repligen shares in Q2 2026, an estimated $250K.
  • Repligen made up 0.73% of NZS Capital's portfolio in Q2 2026, its #43 holding.
  • NZS Capital first reported a position in Repligen in Q2 2023 and has held it in 13 quarters since.
  • NZS Capital's Repligen position peaked at $32.6M in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on NZS Capital's 13F filing for Q2 2026, filed 14 Aug 2026.